Who are HyperHAES vs. RA-solution/NaCl's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hyperhaes-vs-ra-solution-nacl.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

HyperHAES vs. RA-solution/NaCl — Competitive Intelligence Brief

HyperHAES vs. RA-solution/NaCl (HyperHAES vs. RA-solution/NaCl) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Colloid resuscitation fluid / Hypertonic solution. Area: Critical Care / Trauma / Hemorrhagic Shock.

phase 3 Colloid resuscitation fluid / Hypertonic solution Critical Care / Trauma / Hemorrhagic Shock Small molecule Live · refreshed every 30 min

Target snapshot

HyperHAES vs. RA-solution/NaCl (HyperHAES vs. RA-solution/NaCl) — Haukeland University Hospital. HyperHAES is a hypertonic hydroxyethyl starch solution that restores intravascular volume and improves microcirculation through osmotic effects, compared to standard isotonic saline or Ringer's acetate.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
HyperHAES vs. RA-solution/NaCl TARGET	HyperHAES vs. RA-solution/NaCl	Haukeland University Hospital	phase 3	Colloid resuscitation fluid / Hypertonic solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Colloid resuscitation fluid / Hypertonic solution class)

Haukeland University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). HyperHAES vs. RA-solution/NaCl — Competitive Intelligence Brief. https://druglandscape.com/ci/hyperhaes-vs-ra-solution-nacl. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab